<DOC>
	<DOCNO>NCT00426192</DOCNO>
	<brief_summary>After cardiac surgery cardiopulmonar bypass , LPS-stimulated cytokine response previously show depressed . Therefore , trial hypothesis test , whether simple immunomodulting intervention like i.v . adminstration mannitol hemofiltration cardipulmonary bypass attenuate immunosuppressing effect .</brief_summary>
	<brief_title>Effects Hemofiltration Mannitol Treatment Cardiopulmonary-Bypass Induced Immunosuppression</brief_title>
	<detailed_description>Background Cardiac surgery use cardiopulmonary bypass ( CPB ) cause systemic inflammatory response . In addition immune response CPB , significant impairment responsiveness peripheral blood mononuclear cell ( PBMC ) immunological stimulus observe . The aim present study evaluate ability antioxidant therapy mannitol hemofiltration CPB modulate observe immunosuppression CPB . Methods With ethic committee approval , 52 patient undergoing elective CABG-surgery prospectively enrol randomized 3 group ( control , 50 g mannitol iv , hemofiltration CPB ) . Blood sample take induction anesthesia ( T1 ) , 20 min separation CPB ( T2 ) 24 h postoperatively ( T3 ) . Expression density monocytic surface receptor CD14 , HLA-DR expression cytokine release ( TNF-ÔÅ° IL10 ) LPS-stimulation evaluate . Results At T2 , CD14dim cell population maintain intervention group control group significant decrease proinflammatory monocytic phenotype . At T3 , group develop significant shift towards antiinflammatory CD14bright population . No significant difference regard HLA-DR expression cytokine release could demonstrate . Conclusion This study show suppression stimulate immune response CPB alleviate iv administration mannitol hemofiltration . In light data show depression immune response might affect postoperative course patient , result could lead improvement management patient undergo cardiac surgery CPB .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>male patient age 3580 elective CABG surgery previous cardiac surgery ejection fraction &lt; 40 % valvular heart disease myocardial infarction last 3 month evidence concomitant malignant immunologic disease antecedent medication corticosteroid methylxanthines hemoglobin &lt; 12 g/dl body mass index &gt; 30</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Immunedefense Suppression</keyword>
	<keyword>Cardiopulmonary Bypass</keyword>
	<keyword>Mannitol</keyword>
	<keyword>Hemofiltration</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Receptors , Surface CD14</keyword>
</DOC>